Searched for
THREE DOSE VACCINE
These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...- HPV vaccination drive reaches 50 lakh girls in three monthsIndia's free Human Papillomavirus vaccination drive is making significant progress. Nearly 50 lakh doses of the cervical cancer vaccine hav...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...
- India sends measles vaccines, medical supplies to Maldives amid rising casesIndia has provided 20,000 measles vaccine doses and three tonnes of medical supplies to the Maldives. This assistance aims to address incre...
- Serum Institute of India to manufacture Oxford Ebola vaccine backed by $8.6 million CEPI fundingSerum Institute of India will produce clinical trial doses of a new Ebola vaccine from Oxford University. This initiative is backed by fres...
- 90.6% hospital births, 96% plus vaccinations: NFHS-6 reflects India's "accelerated progress" in family health parametersIndia's National Family Health Survey-6 shows significant improvements in maternal and child health. Vaccinations and antenatal care have i...
- What to know about the Bundibugyo virus, a species of Ebola causing an outbreak in CongoA rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...
- Ebola vaccine update: Russia claims a breakthrough; Oxford researchers, Serum Institute of India aim to begin trial in 3 monthsA new Ebola vaccine developed by Russian scientists shows promise against the current outbreak strain in the Democratic Republic of Congo. ...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- From oncology to obesity, Pfizer bets big on India for its next growth wavePfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...
- Covaxin booster dose enhances vaccine effectiveness against Delta, Omicron variants, says ICMR studyThe protective efficacy of Bharat Biotech's Covaxin following two and three-dose immuniszations against the Delta variant and the efficacy ...
- Vaccination of children not likely to happen anytime soon: Health minister MandaviyaThe health minister refused to comment on whether vaccination could be allowed in January next year. "I cannot say when. But not right now,...
- Zydus Cadila agrees to reduce its Covid vaccine price to Rs 265 a dose, final decision soon: SourcesThe indigenously developed world's first DNA-based needle-free COVID-19 vaccine ZyCoV-D received emergency use authorisation from the drug ...
- Zydus vaccine likely to cost Rs 300 a doseHealth secretary Rajesh Bhushan on Thursday had spoken about the pricing. "We are in conversation with the manufacturer. Since it is a thre...
- Zydus Cadila proposes Rs 1900 for three-dose COVID vaccine; Govt negotiating to bring it downThe government had on Thursday said that the indigenously-developed, world's first DNA-based needle-free COVID-19 vaccine by Zydus Cadila w...
- Arvind Kejriwal demands 2.6 crore vaccine doses for inoculation of all in Delhi in next three monthsIn order to vaccinate all people in Delhi, over three crore doses will be required, out of which around 40 lakh have already been received,...
- Zydus Cadila will seek emergency nod for its shot in June: Managing Director Sharvil PatelThe company expects to price the vaccine at a similar price that companies such as Serum Institute of India and Bharat Biotech are charging...
- Cadila Healthcare Working on Needle-free, 2-Dose VaccineThe drug company is conducting phase-3 trials with over 20,000 participants to test whether its three-dose vaccine ZyCoV-D prevents virolog...
- Three month gap between Oxford vaccine jabs provides better efficacy: StudyThe results of the analysis from a phase 3 randomised controlled trial, published in The Lancet journal, suggest that the interval between ...
Load More
